Courtroom scene of appeals court victory upholding speech rights for New York pro-life pregnancy centers against AG Letitia James.
AIによって生成された画像

Appeals court backs New York pregnancy centers’ speech rights in dispute with AG James

AIによって生成された画像
事実確認済み

A coalition of pro-life pregnancy centers secured a legal victory against New York Attorney General Letitia James after the U.S. Court of Appeals for the 2nd Circuit upheld an injunction that protects the centers’ ability to speak about so‑called abortion pill reversal protocols.

On Monday, the U.S. Court of Appeals for the 2nd Circuit affirmed a federal district court’s order granting a preliminary injunction to a coalition of pro-life organizations, concluding that their speech about abortion pill reversal (APR) is protected by the First Amendment.

The ruling leaves in place an earlier injunction that bars New York Attorney General Letitia James from using state business‑fraud and consumer‑protection laws, at least for now, to enforce restrictions on how the groups discuss APR while the case proceeds.

The plaintiffs in the case include the National Institute of Family and Life Advocates (NIFLA), Gianna’s House and Options Care Center, according to JURIST and case summaries.iteturn0search2turn0search6] They were not named as defendants in a separate enforcement action James filed in May 2024 against Heartbeat International and 11 New York crisis pregnancy centers, but said they curtailed their own APR‑related communications for fear of facing similar enforcement.iteturn0search2turn0search0]

James’s May 6, 2024 lawsuit accuses Heartbeat International and the 11 centers of using “false and misleading statements” to advertise APR, which involves administering repeated doses of progesterone to someone who has taken mifepristone, the first drug in a two‑step medication abortion regimen.iteturn0search0] In the complaint and an accompanying press release, James alleges that the defendants promote APR as a safe and effective way to “reverse” a medication abortion despite what her office describes as a lack of credible scientific evidence supporting the treatment’s safety or efficacy, and she characterizes their conduct as fraud, deceptive business practices and false advertising under New York law.iteturn0search0]

“Heartbeat International and the other crisis pregnancy center defendants are spreading dangerous misinformation by advertising ‘abortion reversals’ without any medical and scientific proof,” James said in announcing the lawsuit.iteturn0search0] Major medical groups including the American College of Obstetricians and Gynecologists have also stated that claims about APR are not based on established science and do not meet clinical standards.iteturn0search0turn0search1turn0search8]

Advocates of APR, including networks linked to Heartbeat International, say the protocol is intended for women who reconsider after taking the first abortion drug and seek to continue their pregnancies. They promote a regimen of bioidentical progesterone to counteract the effects of mifepristone and claim significant numbers of pregnancies have been sustained through the treatment, though those figures are disputed and not accepted by major medical authorities.iteturn0search2turn0search8]

The Second Circuit focused on the nature of the plaintiffs’ speech rather than on the medical debate. The panel concluded that the organizations’ APR‑related communications are noncommercial because they are “religiously and morally motivated,” do not generate payment for services or referrals, and simply inform the public about the existence of APR and third‑party providers who offer it.iteturn0search2] On that basis, the court held that New York’s restrictions must satisfy heightened First Amendment scrutiny, and it found the state had not met that burden at this stage of the litigation.iteturn0search2turn0search6]

Alliance Defending Freedom, which represents the NIFLA coalition, welcomed the ruling. In public statements reported by allied advocacy groups, ADF attorney Caroline Lindsay argued that women who regret beginning a medication abortion should be free to hear about APR and decide whether to pursue it, framing the issue as one of access to information and choice.

Separately, the legal fight over how governments may investigate or regulate crisis pregnancy centers has reached the U.S. Supreme Court. On Tuesday, the Court heard oral arguments in a New Jersey case involving First Choice Women’s Resource Centers, a Christian‑based network of pregnancy clinics challenging a subpoena issued by New Jersey Attorney General Matthew Platkin as part of a consumer‑protection probe.iteturn0news12turn0news13] First Choice, represented by Alliance Defending Freedom, contends that the demand for internal records and donor information violates its First Amendment rights; several justices signaled concern about the potential chilling effect such subpoenas could have on donors and advocacy groups more broadly.iteturn0news12turn0news14] While that dispute does not center on APR specifically, it is part of the wider legal battle over how far state officials may go in policing the practices and messaging of anti‑abortion pregnancy centers.

The Second Circuit stressed that its decision in the New York case is preliminary and “does not determine the ultimate constitutionality” of the state’s enforcement efforts, which will be tested further as the lawsuit returns to the district court for additional proceedings.iteturn0search2]

人々が言っていること

Discussions on X largely consist of pro-life advocates, legal organizations, and conservative commentators celebrating the 2nd Circuit Court of Appeals' unanimous ruling upholding the free speech rights of New York pregnancy centers to discuss abortion pill reversal against AG Letitia James. Posters frame it as a victory against government censorship and harassment of pro-life ministries. Legal experts emphasize protection of viewpoint-based speech. A few skeptical users question the legitimacy of abortion pill reversal claims.

関連記事

Illustration depicting U.S. Supreme Court case on New Jersey subpoena against faith-based pregnancy center, symbolizing free speech and privacy rights.
AIによって生成された画像

最高裁判所、信仰に基づく妊娠センター関わるニュージャージー州召喚状争議を審査へ

AIによるレポート AIによって生成された画像 事実確認済み

米国最高裁判所は2025年12月2日、ニュージャージー州のキリスト教系妊娠リソースセンターが州検事総長の召喚状を州裁判所で完全に争う前に連邦裁判所で争うことができるかどうかを審理する。この事件はFirst Choice Women’s Resource Centersとニュージャージー州検事総長Matthew Platkinの同センターの広告・サービス調査、うち中絶薬逆転促進に関するもので、寄付者プライバシー、言論の自由、結社の自由に関する疑問を提起している。

U.S. Supreme Court justices expressed skepticism toward New Jersey’s broad subpoena against a Christian pregnancy center during oral arguments on Tuesday, pressing the state on the basis and scope of its investigation. The case centers on whether the demand for donor and internal records can be challenged in federal court because it allegedly chills the organization’s supporters.

AIによるレポート 事実確認済み

新たな全国調査と一連の強要事例が、共和党議員、州検事総長、擁護団体からのFDAに対する呼びかけを強めており、中絶薬に対するより厳格な安全策の復活を求めている。この圧力は、連邦保健当局がミフェプリストンの安全性を審査中であり、FDAが2番目のジェネリック版を承認したという状況下でも生じている。

20州とコロンビア特別区の当局者による連合が、連邦の長年のホームレス対策イニシアチブに対する新たな制限を停止させるため、トランプ政権を相手に訴訟を提起した。この訴訟はニューヨーク州司法長官レティシア・ジェームズが主導し、住宅都市開発省(HUD)のContinuum of Careプログラムの政策変更を標的にしており、「Housing First」提供者から資金を移すものである。

AIによるレポート 事実確認済み

The New York Times has filed a lawsuit against the Defense Department and Defense Secretary Pete Hegseth, challenging a new Pentagon media policy introduced in September that it says violates constitutional protections for free speech, a free press and due process by sharply limiting journalists’ ability to report information that has not been formally approved by defense officials.

米国最高裁判所は2025年11月10日月曜日、無コメントでケンタッキー州元職員キム・デイビスの請願を却下し、2015年の全国的な同性婚を合法化したObergefell v. Hodgesの再検討を求めていた。デイビスは、同性カップルへの結婚免許発行を拒否したことによる36万ドル超の損害賠償と法的手数料の免除、およびObergefellの再検討を裁判官に求めていたが、裁判所は審査を拒否し、目立った反対意見を発しなかった。

AIによるレポート

米最高裁判所は、連邦通信委員会(FCC)が通信会社に罰金を科す権限を制限する可能性のある事件の審理に同意した。この争いは、2024年にAT&T、Verizon、T-Mobileに対し、顧客の位置データ情報を同意なしに販売したとして総額1億9600万ドルの罰金が科されたことに起因する。通信事業者は、このプロセスが陪審裁判の権利を侵害すると主張し、最近の証券関連判決を引用している。

 

 

 

このウェブサイトはCookieを使用します

サイトを改善するための分析にCookieを使用します。詳細については、プライバシーポリシーをお読みください。
拒否